Ozdemir V, Bremner K E, Naranjo C A
Department of Pharmacology, University of Toronto, Canada.
Ann Med. 1994 Apr;26(2):101-5. doi: 10.3109/07853899409147336.
Treatment of the alcohol withdrawal syndrome is the first step towards the rehabilitation of alcohol-dependent patients. The objectives of treatment are relief of symptoms, prevention of complications and a smooth transition into a long-term rehabilitation programme. Recently, progress has been made in the clinical management of the alcohol withdrawal syndrome through standardization of the assessment using the CIWA-A scale and frequent monitoring of clinical findings, recognition of the efficacy of non-pharmacological interventions (i.e. standardized supportive care) and simplification of pharmacotherapy by optimizing the use of long-acting benzodiadepines via a loading dose technique. Benzodiazepines, because of their cross-tolerance with ethanol, wide margin of safety and low potential for physical dependence and tolerance, are very effective and are the drugs of choice for the treatment of the alcohol withdrawal syndrome.
酒精戒断综合征的治疗是酒精依赖患者康复的第一步。治疗目标是缓解症状、预防并发症以及顺利过渡到长期康复计划。最近,通过使用CIWA - A量表进行标准化评估以及频繁监测临床发现,在酒精戒断综合征的临床管理方面取得了进展;认识到非药物干预(即标准化支持性护理)的疗效,并通过负荷剂量技术优化长效苯二氮䓬类药物的使用来简化药物治疗。苯二氮䓬类药物由于与乙醇有交叉耐受性、安全范围广、身体依赖性和耐受性低,非常有效,是治疗酒精戒断综合征的首选药物。